Washington, D.C., October 1, 2014—Use of specific dietary supplements can have a positive effect on health care costs through avoided hospitalizations related to Coronary Heart Disease (CHD), according to a new article published in the Journal of Dietary Supplements(1). The article, "From Science to Finance—A Tool for Deriving Economic Implications from the Results of Dietary Supplement Clinical Studies," published by Christopher Shanahan and Robert de Lorimier, Ph.D., explores a potential cost-benefit analysis tool that, when applied to a high-risk population (U.S.